For the Inventor, By the Inventor

Enter assignee name

Parkville, Australia

Ctxt Pty Limited

USPTO Granted Patents = 17

EPO Patents = 17

Forward Citations = 13

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Michelle Ang Camerino (13 out of 16 patents)

Paul Anthony Stupple (11 out of 32 patents)

Scott Raymond Walker (9 out of 14 patents)

4. Richard Charles Foitzik (5 out of 12 patents)

5. Benjamin Joseph Morrow (5 out of 7 patents)

6. Ylva Elisabet Bergman Bozikis (5 out of 5 patents)

7. Paul Anthony Stupple (5 out of 5 patents)

8. Ylva Elisabet Bergman (4 out of 7 patents)

9. H Rachel Lagiakos (4 out of 5 patents)

10. Jonathan Grant Hubert (3 out of 3 patents)

11. Scott Channing Sutton (2 out of 15 patents)

12. Pei-Pei Kung (2 out of 15 patents)

13. John Feutrill (2 out of 3 patents)

14. Graeme Irvine Stevenson (2 out of 2 patents)

15. Anthony Nicholas Cuzzupe (2 out of 2 patents)

17 patents: Sort by Forward Citations

1. 12415785 - Compound modulators of sting (2025-09-16),

2. 12384801 - Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting (2025-08-12),

3. 12371425 - Benzisoxazole sulfonamide derivatives (2025-07-29),

4. 12365655 - Compounds (2025-07-22),

5. 11911372 - Compounds (2024-02-27),

6. 11613525 - Substituted condensed thiophenes as modulators of sting (2023-03-28),

7. 11492346 - Benzisoxazole sulfonamide derivatives (2022-11-08),

8. 11028101 - 3-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathies (2021-06-08),

9. 10961256 - PRMT5 inhibitors (2021-03-30),

10. 10787434 - Benzopiperdine derivatives and their use in the treatment of cancer and hemoglobinopathies (2020-09-29),

11. 10745380 - Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathies (2020-08-18),

12. 10647708 - Tetrahydroisoquinoline derived PRMT5-inhibitors (2020-05-12),

13. 10550096 - Tetrahydroisoquinolines as PRMT5 inhibitors (2020-02-04),

14. 10519167 - 3-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathies (2019-12-31),

15. 10494376 - Tetrahydroisoquinoline derived PRMT5-inhibitors (2019-12-03),

CTXT PTY LIMITED is a technology company specializing in providing cutting-edge software and IT solutions for businesses. With a team of highly skilled professionals, CTXT offers tailored services in web development, mobile app development, cloud computing, and artificial intelligence. They strive to deliver innovative solutions that meet their clients' unique requirements and help them stay ahead in the digital world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#4 in Parkville

#205 in Australia

#34,854 in the World

Parkville, Australia

Ctxt Pty Limited

Forward Citations = 13

23 inventors:

Michelle Ang Camerino (13 out of 16 patents)

Paul Anthony Stupple (11 out of 32 patents)

Scott Raymond Walker (9 out of 14 patents)

4. Richard Charles Foitzik (5 out of 12 patents)

5. Benjamin Joseph Morrow (5 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…